Today's Daily Dose brings you news about the status of Bristol Myers and bluebird bio's Idecabtagene vicleucel Biologics License Application and the companies that have released Abstracts for the ASCO 2020 Virtual Meeting and their stock movement.
from RTT - Biotech https://ift.tt/2Z2wccm
via IFTTT
No comments:
Post a Comment